Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode
Authors
Keywords
-
Journal
JAMA Psychiatry
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-10-19
DOI
10.1001/jamapsychiatry.2022.3352
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting
- (2022) Sina Nikayin et al. JAMA Psychiatry
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
- (2021) Roger S. McIntyre et al. AMERICAN JOURNAL OF PSYCHIATRY
- Barriers to the Implementation of Electroconvulsive Therapy (ECT): Results From a Nationwide Survey of ECT Practitioners
- (2021) Samuel T. Wilkinson et al. PSYCHIATRIC SERVICES
- Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT)
- (2021) Joakim Ekstrand et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
- (2020) Laura Basso et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
- (2020) Jennifer L. Phillips et al. BMC Psychiatry
- Prevalence of Treatment for Depression Among US Adults Who Screen Positive for Depression, 2007-2016
- (2020) Taeho Greg Rhee et al. JAMA Psychiatry
- Pharmacological Treatments for Patients with Treatment-Resistant Depression
- (2020) Valerie L. Ruberto et al. Pharmaceuticals
- Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder
- (2020) Dorna Kheirabadi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review
- (2020) Jolien K.E. Veraart et al. JOURNAL OF AFFECTIVE DISORDERS
- Depression
- (2019) Johan Ormel et al. CURRENT OPINION IN PSYCHIATRY
- Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy
- (2019) Alan Weiss et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis
- (2018) Linda van Diermen et al. BRITISH JOURNAL OF PSYCHIATRY
- ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol
- (2018) Sanjay J. Mathew et al. Contemporary Clinical Trials
- Modern Electroconvulsive Therapy
- (2017) Harold A. Sackeim JAMA Psychiatry
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
- (2017) Gerard Sanacora et al. JAMA Psychiatry
- A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study
- (2016) Charles H. Kellner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study
- (2016) Charles H. Kellner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Response of Depression to Electroconvulsive Therapy
- (2015) Aazaz U. Haq et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Relapse Following Successful Electroconvulsive Therapy for Major Depression: A Meta-Analysis
- (2013) Ana Jelovac et al. NEUROPSYCHOPHARMACOLOGY
- Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder
- (2013) Mehdi Ghasemi et al. PSYCHIATRY RESEARCH
- The STAR*D study: treating depression in the real world.
- (2009) B. N Gaynes et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- GABAB Receptors, Schizophrenia and Sleep Dysfunction
- (2009) Joshua Kantrowitz et al. CNS DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now